empty
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle with Mylan and Teva
Hi, what are you looking for?
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle with Mylan and Teva
In the three way takeover battle Mylan is getting nervous.
Three Way Takeover Battle: believes their offer will win approval from Perrigo stockholders.
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
It's tictoc, tictoc, for Teva.
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
– Teva Pharmaceutical Industries Ltd. ((NYSE: TEVA; TASE: TEVA) today announced that the Board of Directors has elected Professor Yitzhak Peterburg as Chairman, effective January 1,...